Although transplantation and consolidation chemo in intermediate-risk patients led to similar overall survival outcomes, outside experts note that the results may not translate to real-life practice.
The Lancet issued expressions of concern about a pair of papers by the Italian doctor, who is currently on probation after a court in Sweden convicted him of causing bodily harm to a patient.
New data published in NEJM suggest that a high-dose trivalent vaccine offers better protection for kids who receive HSCT than a standard-dose quadrivalent vaccine.
Posoleucel, an investigational off-the-shelf T-cell therapy, showed promising safety and efficacy for eradicating multiple viruses in patients who had allogeneic stem cell transplant (allo-SCT).